Patents Assigned to Verus Pharmaceuticals, Inc.
  • Publication number: 20080020003
    Abstract: The present invention relates to method for inducing bronchodilation in a patient in need thereof comprising (a) providing at least one dose of an inhalation mixture comprising a ?2 agonist to said patient; and (b) delivering said inhalation mixture with an inhalation nebulizer, as well as dosage formulations comprising a ?2 agonist.
    Type: Application
    Filed: May 18, 2007
    Publication date: January 24, 2008
    Applicant: Verus Pharmaceuticals, Inc.
    Inventors: Malcolm Hill, Hemant Deshmukh, Elaine Phillips
  • Publication number: 20070276048
    Abstract: The present invention relates to unit dose formulations comprising an inhalable albuterol solution, wherein the inhalation albuterol solution is formulated with albuterol free base, a tonicity adjusting agent, a pH adjusting agent and water. Methods of preparing the unit dose formulation are also provided.
    Type: Application
    Filed: May 18, 2007
    Publication date: November 29, 2007
    Applicant: Verus Pharmaceuticals, Inc.
    Inventors: Hemant Deshmukh, Elaine Phillips, Malcolm Hill
  • Publication number: 20070249572
    Abstract: The present invention relates to methods and systems for the delivery of a corticosteroid comprising (1) an inhalable aqueous mixture comprising a corticosteroid and a solubility enhancer and (2) an inhalable nebulizer, wherein the delivery of the aqueous mixture comprising the corticosteroid by the nebulizer results in an enhanced pharmacokinetic profile of the corticosteroid as compared to conventional inhalable therapies and/or increase lung deposition.
    Type: Application
    Filed: December 20, 2006
    Publication date: October 25, 2007
    Applicant: Verus Pharmaceuticals, Inc.
    Inventor: Malcolm Hill
  • Publication number: 20070219498
    Abstract: An automatic injector comprising an improved energy management system as well as an improved shock absorber system adapted to reduce dynamic stresses on internal device components is provided. In particular, a shock absorber system comprising a stationary shock absorber is provided. In some embodiments, the stationary shock absorber is located in the nose of the automatic injector.
    Type: Application
    Filed: February 28, 2007
    Publication date: September 20, 2007
    Applicant: Verus Pharmaceuticals, Inc.
    Inventors: Greg Malone, Eric Warner
  • Publication number: 20070197486
    Abstract: The present invention relates to methods and systems for the delivery of a corticosteroid comprising (1) an inhalable aqueous mixture comprising a corticosteroid and a solubility enhancer and (2) an inhalable nebulizer, wherein the delivery of the aqueous mixture comprising the corticosteroid by the nebulizer results in an enhanced pharmacokinetic profile of the corticosteroid as compared to conventional inhalable therapies and/or increase lung deposition.
    Type: Application
    Filed: December 19, 2006
    Publication date: August 23, 2007
    Applicant: Verus Pharmaceuticals, Inc.
    Inventor: Malcolm Hill
  • Publication number: 20070197487
    Abstract: The present invention relates to methods and systems for the delivery of a corticosteroid comprising (1) an inhalable aqueous mixture comprising a corticosteroid and a solubility enhancer and (2) an inhalable nebulizer, wherein the delivery of the aqueous mixture comprising the corticosteroid by the nebulizer results in an enhanced pharmacokinetic profile of the corticosteroid as compared to conventional inhalable therapies.
    Type: Application
    Filed: December 19, 2006
    Publication date: August 23, 2007
    Applicant: Verus Pharmaceuticals, Inc.
    Inventor: Malcolm Hill
  • Publication number: 20070191599
    Abstract: The present invention relates to methods of manufacturing compositions comprising a corticosteriod and at least one solubility enhancer, as well as compositions made by these methods.
    Type: Application
    Filed: February 15, 2007
    Publication date: August 16, 2007
    Applicant: VERUS PHARMACEUTICALS, INC.
    Inventors: Malcolm Hill, Cynthia LiCalsi, Troy Christensen
  • Publication number: 20070191327
    Abstract: Novel methods of sterilizing corticosteroid solutions resulting in improved final yield of active corticosteroid ingredient.
    Type: Application
    Filed: February 15, 2007
    Publication date: August 16, 2007
    Applicant: VERUS PHARMACEUTICALS, INC.
    Inventors: Malcolm Hill, Cynthia LiCalsi
  • Publication number: 20070191323
    Abstract: A corticosteroid mixture, such as a budesonide solution, is prepared by the active and inactive ingredients of the mixture under oxygen-depleted conditions. The resulting mixture demonstrates superior stability of the active pharmaceutical ingredient corticosteroid. The invention provides novel methods of manufacturing corticosteroid mixtures, wherein the resulting mixtures possess superior stability as compared to known methods.
    Type: Application
    Filed: February 15, 2007
    Publication date: August 16, 2007
    Applicant: VERUS PHARMACEUTICALS, INC.
    Inventors: Malcolm Hill, Cynthia LiCalsi
  • Publication number: 20070185066
    Abstract: The present invention relates to methods and systems for the delivery of a corticosteroid comprising (1) an inhalable aqueous mixture comprising a corticosteroid and a solubility enhancer and (2) an inhalable nebulizer, wherein the delivery of the aqueous mixture comprising the corticosteroid by the nebulizer results in an enhanced pharmacokinetic profile of the corticosteroid as compared to conventional inhalable therapies and/or increase lung deposition.
    Type: Application
    Filed: December 19, 2006
    Publication date: August 9, 2007
    Applicant: Verus Pharmaceuticals, Inc.
    Inventor: Malcolm Hill
  • Publication number: 20070178049
    Abstract: The present invention relates to methods and systems for the delivery of a corticosteroid comprising (1) an inhalable aqueous mixture comprising a corticosteroid and a solubility enhancer and (2) an inhalable nebulizer, wherein the delivery of the aqueous mixture comprising the corticosteroid by the nebulizer results in an enhanced pharmacokinetic profile of the corticosteroid as compared to conventional inhalable therapies, and/or increased lung deposition.
    Type: Application
    Filed: December 19, 2006
    Publication date: August 2, 2007
    Applicant: Verus Pharmaceuticals, Inc.
    Inventor: Malcolm Hill
  • Publication number: 20070178050
    Abstract: The present invention relates to methods and systems for the delivery of a corticosteroid comprising (1) an inhalable aqueous mixture comprising a corticosteroid and a solubility enhancer and (2) an inhalable nebulizer, wherein the delivery of the aqueous mixture comprising the corticosteroid by the nebulizer results in an enhanced pharmacokinetic profile of the corticosteroid as compared to conventional inhalable therapies.
    Type: Application
    Filed: December 19, 2006
    Publication date: August 2, 2007
    Applicant: Verus Pharmaceuticals, Inc.
    Inventor: Malcolm Hill
  • Publication number: 20070160542
    Abstract: The present invention relates to methods and systems for the delivery of a corticosteroid comprising (1) an inhalable aqueous mixture comprising a corticosteroid and a solubility enhancer and (2) an inhalable nebulizer, wherein the delivery of the aqueous mixture comprising the corticosteroid by the nebulizer results in an enhanced pharmacokinetic profile of the corticosteroid as compared to conventional inhalable therapies and/or increased lung deposition.
    Type: Application
    Filed: December 19, 2006
    Publication date: July 12, 2007
    Applicant: Verus Pharmaceuticals, Inc.
    Inventor: Malcolm Hill